Clinical Observation on the Treatment of Severe Acute Pancreatitis
Abstract
Objective: To investigate the medical treatment methods, efficacy and progress of acute severe pancreatitis. Methods: 60 patients of acute severe pancreatitis in our hospital was selected from October 2007 to December 2007. They were divided into two groups namely, the observation group and control group. The control group was treated by routine western medicine treatment with metronidazole, whereas the observation group received the combined treatment of conventional western medicine with paeonol, rhubarb and other Chinese medicine. After the medical treatment was found to be ineffective, the patients then underwent for surgery. Both groups were observed and compared in terms of the cure rate, death rate, symptom relief time, fever duration, recovery time of intestinal peristalsis and hospitalization. Result: The cure rate, symptom relief time and hospitalization time were significantly different between the two groups, with the observation group was significantly better than the control group (p < 0.05). Conclusion: The usage of metronidazole, Cortex Moutan, rhubarb and other traditional Chinese medicine in the treatment of severe acute pancreatitis (SAP) revealed good clinical efficacy, which is worth to be fostered in clinical application.
References
2. Li J. Clinical study of comprehensive treatment of severe acute pancreatitis. Journal of Jinzhou Medical College. 2005;26(3):21−24.
3. Yang Y. Analysis of 24 cases of acute severe acute pancreatitis. Chongqing Medicine. 2004;1(33):178−179.
4. Li TQ. Medical treatment of severe acute pancreatitis. Central Plains Medical Journal. 2004;7(31):16−17.
5. Liu TF. Progress in the treatment of acute severe pancreatitis. Heilongjiang Medical Journal. 2002;10(4):133−107.
6. Zhang YP. Clinical observation on 48 cases of severe acute pancreatitis medical treatment. Acta Academiae Medicinae Zunyi. 2007;30(3):249−188.
Copyright (c) 2015 Wen Zou
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.